 | • レポートコード：QFJ1-4850 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、季節性情動障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（光線療法、薬物治療、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・季節性情動障害治療薬の市場動向 ・企業の競争状況、市場シェア ・季節性情動障害治療薬の種類別市場規模と予測2016-2027（光線療法、薬物治療、その他） ・季節性情動障害治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・季節性情動障害治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・季節性情動障害治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・季節性情動障害治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・季節性情動障害治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・季節性情動障害治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Pfizer、Roche、Eli Lily、GlaxoSmithKline、Teva Pharmaceuticals、Bausch Health Companies、Mylan、Sanofi、Novartis、Johnson & Johnson、Koninklijke Philips、Beurer GmbH、Lucimed (Luminette)） ・結論 |
Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.
Market Analysis and Insights: Global Seasonal Affective Disorder Therapeutics Market
The global Seasonal Affective Disorder Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Seasonal Affective Disorder Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Seasonal Affective Disorder Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Seasonal Affective Disorder Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Seasonal Affective Disorder Therapeutics market.
Global Seasonal Affective Disorder Therapeutics Scope and Market Size
Seasonal Affective Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Light Therapy (Phototherapy)
Medication
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Pfizer
Roche
Eli Lily
GlaxoSmithKline
Teva Pharmaceuticals
Bausch Health Companies
Mylan
Sanofi
Novartis
Johnson & Johnson
Koninklijke Philips
Beurer GmbH
Lucimed (Luminette)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Light Therapy (Phototherapy)
1.2.3 Medication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Seasonal Affective Disorder Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Affective Disorder Therapeutics Market Perspective (2016-2027)
2.2 Seasonal Affective Disorder Therapeutics Growth Trends by Regions
2.2.1 Seasonal Affective Disorder Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Seasonal Affective Disorder Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Seasonal Affective Disorder Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Seasonal Affective Disorder Therapeutics Industry Dynamic
2.3.1 Seasonal Affective Disorder Therapeutics Market Trends
2.3.2 Seasonal Affective Disorder Therapeutics Market Drivers
2.3.3 Seasonal Affective Disorder Therapeutics Market Challenges
2.3.4 Seasonal Affective Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Affective Disorder Therapeutics Players by Revenue
3.1.1 Global Top Seasonal Affective Disorder Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Seasonal Affective Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Seasonal Affective Disorder Therapeutics Revenue
3.4 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Affective Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Affective Disorder Therapeutics Revenue in 2020
3.5 Seasonal Affective Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Seasonal Affective Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Affective Disorder Therapeutics Breakdown Data by Type
4.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2022-2027)
5 Seasonal Affective Disorder Therapeutics Breakdown Data by Application
5.1 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Seasonal Affective Disorder Therapeutics Market Size (2016-2027)
6.2 North America Seasonal Affective Disorder Therapeutics Market Size by Type
6.2.1 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2027)
6.3 North America Seasonal Affective Disorder Therapeutics Market Size by Application
6.3.1 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2027)
6.4 North America Seasonal Affective Disorder Therapeutics Market Size by Country
6.4.1 North America Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Seasonal Affective Disorder Therapeutics Market Size (2016-2027)
7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type
7.2.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2027)
7.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application
7.3.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2027)
7.4 Europe Seasonal Affective Disorder Therapeutics Market Size by Country
7.4.1 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Seasonal Affective Disorder Therapeutics Market Size (2016-2027)
9.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type
9.2.1 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application
9.3.1 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Seasonal Affective Disorder Therapeutics Market Size by Country
9.4.1 Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Seasonal Affective Disorder Therapeutics Introduction
11.1.4 Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Seasonal Affective Disorder Therapeutics Introduction
11.2.4 Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Seasonal Affective Disorder Therapeutics Introduction
11.3.4 Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Eli Lily
11.4.1 Eli Lily Company Details
11.4.2 Eli Lily Business Overview
11.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Introduction
11.4.4 Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.4.5 Eli Lily Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Introduction
11.6.4 Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Bausch Health Companies
11.7.1 Bausch Health Companies Company Details
11.7.2 Bausch Health Companies Business Overview
11.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Introduction
11.7.4 Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.7.5 Bausch Health Companies Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Seasonal Affective Disorder Therapeutics Introduction
11.8.4 Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Seasonal Affective Disorder Therapeutics Introduction
11.9.4 Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Seasonal Affective Disorder Therapeutics Introduction
11.10.4 Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Introduction
11.11.4 Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.11.5 Johnson & Johnson Recent Development
11.12 Koninklijke Philips
11.12.1 Koninklijke Philips Company Details
11.12.2 Koninklijke Philips Business Overview
11.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Introduction
11.12.4 Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.12.5 Koninklijke Philips Recent Development
11.13 Beurer GmbH
11.13.1 Beurer GmbH Company Details
11.13.2 Beurer GmbH Business Overview
11.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Introduction
11.13.4 Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.13.5 Beurer GmbH Recent Development
11.14 Lucimed (Luminette)
11.14.1 Lucimed (Luminette) Company Details
11.14.2 Lucimed (Luminette) Business Overview
11.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Introduction
11.14.4 Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021)
11.14.5 Lucimed (Luminette) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Seasonal Affective Disorder Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Light Therapy (Phototherapy)
Table 3. Key Players of Medication
Table 4. Key Players of Others
Table 5. Global Seasonal Affective Disorder Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Seasonal Affective Disorder Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Seasonal Affective Disorder Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Seasonal Affective Disorder Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Seasonal Affective Disorder Therapeutics Market Share by Regions (2022-2027)
Table 11. Seasonal Affective Disorder Therapeutics Market Trends
Table 12. Seasonal Affective Disorder Therapeutics Market Drivers
Table 13. Seasonal Affective Disorder Therapeutics Market Challenges
Table 14. Seasonal Affective Disorder Therapeutics Market Restraints
Table 15. Global Seasonal Affective Disorder Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Seasonal Affective Disorder Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Seasonal Affective Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2020)
Table 18. Ranking of Global Top Seasonal Affective Disorder Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Seasonal Affective Disorder Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
Table 22. Date of Enter into Seasonal Affective Disorder Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Seasonal Affective Disorder Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Seasonal Affective Disorder Therapeutics Product
Table 65. Allergan Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Seasonal Affective Disorder Therapeutics Product
Table 70. Pfizer Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Seasonal Affective Disorder Therapeutics Product
Table 75. Roche Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Eli Lily Company Details
Table 78. Eli Lily Business Overview
Table 79. Eli Lily Seasonal Affective Disorder Therapeutics Product
Table 80. Eli Lily Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Eli Lily Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Seasonal Affective Disorder Therapeutics Product
Table 85. GlaxoSmithKline Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Teva Pharmaceuticals Company Details
Table 88. Teva Pharmaceuticals Business Overview
Table 89. Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Product
Table 90. Teva Pharmaceuticals Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceuticals Recent Development
Table 92. Bausch Health Companies Company Details
Table 93. Bausch Health Companies Business Overview
Table 94. Bausch Health Companies Seasonal Affective Disorder Therapeutics Product
Table 95. Bausch Health Companies Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Bausch Health Companies Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Seasonal Affective Disorder Therapeutics Product
Table 104. Sanofi Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Novartis Company Details
Table 107. Novartis Business Overview
Table 108. Novartis Seasonal Affective Disorder Therapeutics Product
Table 109. Novartis Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Novartis Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Seasonal Affective Disorder Therapeutics Product
Table 114. Johnson & Johnson Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Koninklijke Philips Company Details
Table 117. Koninklijke Philips Business Overview
Table 118. Koninklijke Philips Seasonal Affective Disorder Therapeutics Product
Table 119. Koninklijke Philips Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 120. Koninklijke Philips Recent Development
Table 121. Beurer GmbH Company Details
Table 122. Beurer GmbH Business Overview
Table 123. Beurer GmbH Seasonal Affective Disorder Therapeutics Product
Table 124. Beurer GmbH Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 125. Beurer GmbH Recent Development
Table 126. Lucimed (Luminette) Company Details
Table 127. Lucimed (Luminette) Business Overview
Table 128. Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Product
Table 129. Lucimed (Luminette) Revenue in Seasonal Affective Disorder Therapeutics Business (2016-2021) & (US$ Million)
Table 130. Lucimed (Luminette) Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Affective Disorder Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Light Therapy (Phototherapy) Features
Figure 3. Medication Features
Figure 4. Others Features
Figure 5. Global Seasonal Affective Disorder Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Seasonal Affective Disorder Therapeutics Report Years Considered
Figure 10. Global Seasonal Affective Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Seasonal Affective Disorder Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Seasonal Affective Disorder Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Seasonal Affective Disorder Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Seasonal Affective Disorder Therapeutics Market Share by Players in 2020
Figure 15. Global Top Seasonal Affective Disorder Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Seasonal Affective Disorder Therapeutics Revenue in 2020
Figure 17. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Seasonal Affective Disorder Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Seasonal Affective Disorder Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Seasonal Affective Disorder Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Seasonal Affective Disorder Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Seasonal Affective Disorder Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Seasonal Affective Disorder Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Seasonal Affective Disorder Therapeutics Market Share by Region (2016-2027)
Figure 39. China Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Seasonal Affective Disorder Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Seasonal Affective Disorder Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Seasonal Affective Disorder Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Seasonal Affective Disorder Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 61. Eli Lily Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 64. Bausch Health Companies Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 69. Koninklijke Philips Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 70. Beurer GmbH Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 71. Lucimed (Luminette) Revenue Growth Rate in Seasonal Affective Disorder Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の心的外傷後ストレス障害治療薬市場規模・現状・予測（2021年-2027年） The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication. Market Analysis and Insights: Global Post-Traumatic Stress Disorder Therapeutics Market The global Post-Traumatic Stress Disorder Therapeutics market size is projected to reach US$ XX million by…- 世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年） CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked genetic condition which results in early-onset, difficult to control seizures and severe neuro-developmental impairment. CDKL5 stands for cyclin-dependent kinase-like 5 and mutations in this gene were fi…
- 世界の代謝性疾患治療薬市場規模・現状・予測（2021年-2027年） Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market. Market Analysis and Insights: Global Metabolic Disorder Therapeutics Market The global Metabolic Disorder Therapeutic…
- 世界の神経変性疾患治療薬市場規模・現状・予測（2021年-2027年） The goal of therapeutic development for neurodegenerative disorders is to develop drugs that slow down or stop the neurodegenerative process. So-called neuroprotective, or disease-modifying, therapies would not only treat the symptoms but slow the continued loss of neurons in disease. Market Analysi…
- 世界の視神経スペクトラム障害（NMOSD）市場規模・現状・予測（2021年-2027年） Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorder of the brain and spinal cord dominated by inflammation of the optic nerve (optic neuritis) and the spinal cord (myelitis). Classically, it was felt to be a monophasic illness, consisting of episodes of…